
Sign up to save your podcasts
Or


Today on the Medscape Medical Minute: Extending the effects of ketamine in treatment-resistant depression; how obstetrics ERs are making money for private equity firms; and how changes in abortion access are triggering a surge in vasectomy demand.
By MedscapeToday on the Medscape Medical Minute: Extending the effects of ketamine in treatment-resistant depression; how obstetrics ERs are making money for private equity firms; and how changes in abortion access are triggering a surge in vasectomy demand.